Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SMMT | UTHR | NBIX | ||
| Company | Summit Therapeu ADR | United Therapeutic | Neurocrine Bioscienc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 24.55 | 578.88 | 129.00 | ||
| High | 25.48 | 592.48 | 133.74 | ||
| Low | 24.06 | 574.59 | 128.41 | ||
| Latest | 25.15 | 588.38 | 133.25 | ||
| Change | +0.73 | +7.87 | +4.84 | ||
| % Change | +2.99% | +1.36% | +3.77% | ||
| Volume | 4,899,800 | 682,400 | 1,728,400 | ||
| 20-Day Average Volume | 3,071,135 | 672,830 | 1,162,040 | ||
| Previous Close | 24.42 | 580.51 | 128.41 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 19.00 | 562.34 | 130.32 | ||
| 20-Day Raw Stochastic | 96.74% | 78.40% | 89.55% | ||
| 20-Day Relative Strength | 77.32 | 62.87 | 52.77 | ||
| Weighted Alpha | +36.70 | +89.84 | +15.62 | ||
| Today's Opinion | 24% Buy | 100% Buy | 72% Sell | ||
| Previous Opinion | 24% Buy | 100% Buy | 100% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +27.86% since 04/10/26 | +2.91% since 04/10/26 | +3.38% since 04/10/26 | ||
| Low | 19.52 on 04/13/26 | 569.70 on 04/13/26 | 125.64 on 04/13/26 | ||
| High | 25.48 on 04/17/26 | 592.48 on 04/17/26 | 133.74 on 04/17/26 | ||
| 1-Month | |||||
| %Chg | +58.68% since 03/17/26 | +8.96% since 03/17/26 | +1.94% since 03/17/26 | ||
| Low | 15.25 on 03/19/26 | 517.59 on 03/24/26 | 125.11 on 03/24/26 | ||
| High | 25.48 on 04/17/26 | 607.89 on 03/30/26 | 134.20 on 04/07/26 | ||
| 3-Month | |||||
| %Chg | +47.59% since 01/16/26 | +26.55% since 01/16/26 | +0.65% since 01/16/26 | ||
| Low | 13.83 on 02/05/26 | 455.63 on 01/20/26 | 122.14 on 02/12/26 | ||
| High | 25.48 on 04/17/26 | 607.89 on 03/30/26 | 142.82 on 02/10/26 | ||
| 6-Month | |||||
| %Chg | +19.82% since 10/17/25 | +35.78% since 10/17/25 | -4.88% since 10/17/25 | ||
| Low | 13.83 on 02/05/26 | 409.07 on 10/28/25 | 122.14 on 02/12/26 | ||
| High | 25.48 on 04/17/26 | 607.89 on 03/30/26 | 160.18 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 19,516,828 | 25,787,516 | 13,402,551 | ||
| Shares Outstanding, K | 776,017 | 43,828 | 100,582 | ||
| Annual Sales | 0 | 3,182,700,000 | 2,860,500,000 | ||
| Annual Net Income | -1,079,590,000 | 1,334,700,000 | 478,600,000 | ||
| Last Quarter Sales | 0 | 790,200,000 | 805,500,000 | ||
| Last Quarter Net Income | -219,170,000 | 364,300,000 | 153,700,000 | ||
| 60-Month Beta | -1.36 | 0.75 | 0.35 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.29 on 02/23/26 | 7.70 on 02/25/26 | 1.88 on 02/11/26 | ||
| Latest Earnings Date | 05/07/26 | 04/29/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.81 | 27.85 | ||